Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3052	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3053	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3054
Common abbreviation	PON1	PON2	PON3
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:9204, http://www.uniprot.org/uniprot/P27169	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:9205, http://www.uniprot.org/uniprot/Q15165	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:9206, http://www.uniprot.org/uniprot/Q15166
EC number	http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.8.1 An aryl dialkyl phosphate + H(2)O <=> dialkyl phosphate + an aryl alcohol http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.2 A phenyl acetate + H(2)O <=> a phenol + acetate http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.81 An N‐acyl‐L‐homoserine lactone + H(2)O <=> an N‐acyl‐L‐homoserine	http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.2 A phenyl acetate + H(2)O <=> a phenol + acetate http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.81 A N‐acyl‐L‐homoserine lactone + H(2)O <=> a N‐acyl‐L‐homoserine	http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.8.1 An aryl dialkyl phosphate + H(2)O <=> dialkyl phosphate + an aryl alcohol http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.2 A phenyl acetate + H(2)O <=> a phenol + acetate http://www.genome.jp/dbget‐bin/www_bget?ec:3.1.1.81 A N‐acyl‐L‐homoserine lactone + H(2)O <=> a N‐acyl‐L‐homoserine
Comments	PON1 forms homodimers. Loss‐of‐function mutations in PON1 are associated with microvascular complications of diabetes [http://www.ncbi.nlm.nih.gov/pubmed/11918623?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/9661650?dopt=AbstractPlus].	PON2 forms heterotrimers [http://www.ncbi.nlm.nih.gov/pubmed/15772423?dopt=AbstractPlus].	PON3 likely forms heterodimers in vivo [http://www.ncbi.nlm.nih.gov/pubmed/15772423?dopt=AbstractPlus].